EndorTech

Synthetic Beta‑Endorphin Aerosol Platform for Pain Relief

Health Tech & Life Sciences
non_active
Pre-Funding Tel Aviv-Yafo, Israel Founded 2023
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2023
Headcount
1
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

EndorTech delivers commercial quantities of synthetic biological beta Endorphin, as a natural alternative to the current opioid Pain killers , with no side effects and at a very worthwhile price, rendering the old methods obsolete.

EndorTech developed a patented disruptive revolutionize mechanism using pure synthetic aerosoled beta Endorphin, which is a smart protein brain food (neuropeptide -delivering messages between neurons by a specific sequence of amino acids) produced in tiny quantities and quickly drain the reservoir.

The company's cutting-edge aerosol technology allows you to inhale endorphins, providing rapid pain relief by directly targeting the source of discomfort. This innovative delivery system ensures quick and effective pain relief without the need for pills or injections.

Q&A

What is EndorTech's primary focus?
EndorTech is focused on developing a synthetic Beta-Endorphin aerosol platform for pain relief, offering a natural alternative to opioid pain killers.
When was EndorTech founded?
EndorTech was founded in June 2023.
What is EndorTech's current operational status?
EndorTech is currently non-active and ceased to operate in June 2026.
What is EndorTech's current funding stage?
EndorTech is in the Pre-Funding stage.
Does EndorTech hold any patents?
Yes, EndorTech holds one patent related to its disruptive mechanism for delivering synthetic aerosoled beta Endorphin.
Who is the Co-founder and CEO of EndorTech?
Ronen Sasson is the Co-founder and CEO of EndorTech.
What sector does EndorTech operate in?
EndorTech operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.

Team · 1

Ronen Sasson
Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalspain-reliefdrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/101194662

Identifiers & details

Founded2023-6
Employees (exact)1

Radar intelligence

Web history (Wayback)

Domainendortech.com